
Benjamin L. Lebron
Examiner (ID: 7336, Phone: (571)272-0475 , Office: P/1777 )
| Most Active Art Unit | 1777 |
| Art Unit(s) | 1777, 1773 |
| Total Applications | 617 |
| Issued Applications | 402 |
| Pending Applications | 48 |
| Abandoned Applications | 180 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10450665
[patent_doc_number] => 20150335678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'METHOD OF ACTIVATING STEM CELLS IN AN ANIMAL AND THE USE OF CHLORINE DIOXIDE FOR PREPARING MEDICINES FOR ACTIVATING STEM CELLS IN AN ANIMAL'
[patent_app_type] => utility
[patent_app_number] => 14/647698
[patent_app_country] => US
[patent_app_date] => 2013-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26541
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647698
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/647698 | METHOD OF ACTIVATING STEM CELLS IN AN ANIMAL AND THE USE OF CHLORINE DIOXIDE FOR PREPARING MEDICINES FOR ACTIVATING STEM CELLS IN AN ANIMAL | Oct 25, 2013 | Abandoned |
Array
(
[id] => 10346074
[patent_doc_number] => 20150231079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'Pharmaceutical Antiretroviral Composition'
[patent_app_type] => utility
[patent_app_number] => 14/429651
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7836
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429651
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429651 | Pharmaceutical antiretroviral composition | Oct 22, 2013 | Issued |
Array
(
[id] => 10365708
[patent_doc_number] => 20150250713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Pharmaceutical Composition'
[patent_app_type] => utility
[patent_app_number] => 14/431561
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4676
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431561 | Pharmaceutical Composition | Oct 22, 2013 | Abandoned |
Array
(
[id] => 10466952
[patent_doc_number] => 20150351967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Bio-Absorbable Medicament-Eluting Ventilation Tube'
[patent_app_type] => utility
[patent_app_number] => 14/432392
[patent_app_country] => US
[patent_app_date] => 2013-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4771
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432392
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432392 | Bio-Absorbable Medicament-Eluting Ventilation Tube | Sep 29, 2013 | Abandoned |
Array
(
[id] => 9362845
[patent_doc_number] => 20140072718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'NON-CAKING POTASSIUM CHLORIDE COMPOSITION, PREPARATION PROCESS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/019749
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7742
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14019749
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/019749 | NON-CAKING POTASSIUM CHLORIDE COMPOSITION, PREPARATION PROCESS AND USE THEREOF | Sep 5, 2013 | Abandoned |
Array
(
[id] => 9450000
[patent_doc_number] => 20140121170
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2014-05-01
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/015438
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10754
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/015438 | Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles | Aug 29, 2013 | Issued |
Array
(
[id] => 9262222
[patent_doc_number] => 20130344151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'SOLID PHARMACEUTICAL COMPOSITION COMPRISING TELITHROMYCIN'
[patent_app_type] => utility
[patent_app_number] => 14/014677
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3269
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14014677
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/014677 | Solid pharmaceutical composition comprising telithromycin | Aug 29, 2013 | Issued |
Array
(
[id] => 9450000
[patent_doc_number] => 20140121170
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2014-05-01
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/015438
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10754
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/015438 | Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles | Aug 29, 2013 | Issued |
Array
(
[id] => 9491760
[patent_doc_number] => 20140142165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'THERAPEUTIC PARTICLES SUITABLE FOR PARENTERAL ADMINISTRATION AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/015549
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13678
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015549
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/015549 | Therapeutic particles suitable for parenteral administration and methods of making and using same | Aug 29, 2013 | Issued |
Array
(
[id] => 10627547
[patent_doc_number] => 09345687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Pharmaceutical compositions of anisomelic acid and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/423711
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7271
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423711
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/423711 | Pharmaceutical compositions of anisomelic acid and the use thereof | Aug 27, 2013 | Issued |
Array
(
[id] => 11873630
[patent_doc_number] => 09745387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Partially cross-linked esterified cellulose ethers'
[patent_app_type] => utility
[patent_app_number] => 14/420985
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15277
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420985
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420985 | Partially cross-linked esterified cellulose ethers | Aug 14, 2013 | Issued |
Array
(
[id] => 10837568
[patent_doc_number] => 08865240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Process for manufacturing chewable dosage forms for drug delivery and products thereof'
[patent_app_type] => utility
[patent_app_number] => 13/967182
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4734
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967182
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967182 | Process for manufacturing chewable dosage forms for drug delivery and products thereof | Aug 13, 2013 | Issued |
Array
(
[id] => 10305326
[patent_doc_number] => 20150190326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'COSMETIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/420045
[patent_app_country] => US
[patent_app_date] => 2013-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12771
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420045
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420045 | Cosmetic compositions | Jul 31, 2013 | Issued |
Array
(
[id] => 9162031
[patent_doc_number] => 20130310308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN'
[patent_app_type] => utility
[patent_app_number] => 13/950202
[patent_app_country] => US
[patent_app_date] => 2013-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19226
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13950202
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/950202 | Method of inhibiting clostridium difficile by administration of oritavancin | Jul 23, 2013 | Issued |
Array
(
[id] => 9162453
[patent_doc_number] => 20130310730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'Methods And Compositions For Administering A Specific Wavelength Phototherapy'
[patent_app_type] => utility
[patent_app_number] => 13/948090
[patent_app_country] => US
[patent_app_date] => 2013-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4749
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13948090
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/948090 | Methods And Compositions For Administering A Specific Wavelength Phototherapy | Jul 21, 2013 | Abandoned |
Array
(
[id] => 9648120
[patent_doc_number] => 08802129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Methods for treating retinopathy with extended therapeutic effect'
[patent_app_type] => utility
[patent_app_number] => 13/946294
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 22774
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946294
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/946294 | Methods for treating retinopathy with extended therapeutic effect | Jul 18, 2013 | Issued |
Array
(
[id] => 11772412
[patent_doc_number] => 09381163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Floating capsules encapsulating particles loaded with one or more drugs'
[patent_app_type] => utility
[patent_app_number] => 14/415485
[patent_app_country] => US
[patent_app_date] => 2013-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 33
[patent_no_of_words] => 9027
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415485
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/415485 | Floating capsules encapsulating particles loaded with one or more drugs | Jul 7, 2013 | Issued |
Array
(
[id] => 9222445
[patent_doc_number] => 20140017220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'TREATMENT OF OPHTHALMIC CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/932842
[patent_app_country] => US
[patent_app_date] => 2013-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11626
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13932842
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/932842 | Treatment of ophthalmic conditions | Jun 30, 2013 | Issued |
Array
(
[id] => 10191345
[patent_doc_number] => 09220238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Molded or extruded cork composite and method of manufacturing compressed cork pet products and pet toys made from the same'
[patent_app_type] => utility
[patent_app_number] => 13/929855
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 2907
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929855
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/929855 | Molded or extruded cork composite and method of manufacturing compressed cork pet products and pet toys made from the same | Jun 27, 2013 | Issued |
Array
(
[id] => 10272574
[patent_doc_number] => 20150157567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'INHALATION COMPOSITIONS COMPRISING MUSCARINIC RECEPTOR ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 14/412595
[patent_app_country] => US
[patent_app_date] => 2013-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17633
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412595 | Inhalation compositions comprising muscarinic receptor antagonist | Jun 26, 2013 | Issued |